American Oncology Network, Inc.

American Oncology Network, Inc.

AONC
American Oncology Network, Inc.US flagOther OTC
10.00
USD
-2.00
- -
292.48MMarket Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
725
944
1,150
1,279
1,759
+ Sales & Services Revenue
725
944
1,150
1,279
1,759
- Cost of Revenue
659
866
1,054
1,196
1,642
+ Cost of Goods & Services
659
866
1,054
1,196
1,642
Gross Profit
66
78
95
83
118
+ Other Operating Income
- -
- -
- -
- -
- -
- Operating Expenses
44
77
87
101
134
+ Selling, General & Admin
44
77
87
101
134
+ Research & Development
- -
- -
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
22
1
9
-18
-16
- Non-Operating (Income) Loss
1
1
6
45
9
+ Interest Expense, Net
1
1
3
5
4
+ Interest Expense
1
1
3
6
7
- Interest Income
- -
- -
- -
1
3
+ Other Non-Op (Income) Loss
- -
-1
3
39
5
Pretax Income
21
- -
3
-63
-25
- Income Tax Expense (Benefit)
-1
- -
- -
- -
2
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
22
- -
3
-63
-27
- Net Extraordinary Losses (Gains)
- -
- -
- -
-115
-46
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
-115
-46
Income (Loss) Incl. MI
22
- -
3
52
19
- Minority Interest
- -
- -
- -
58
23
Net Income, GAAP
22
- -
3
-6
-4
- Preferred Dividends
- -
- -
- -
4
6
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
22
- -
3
-9
-10
EBIT
22
1
9
-18
-16
EBITDA
26
7
26
-1
3
EBITDA Margin (%)
3.55
0.74
2.26
-0.09
0.19
EBITA
22
1
9
-18
-16
Gross Margin (%)
9.12
8.26
8.3
6.47
6.7
Operating Margin (%)
3.05
0.1
0.77
-1.4
-0.91
Profit Margin (%)
3.03
-0.01
0.23
-0.43
-0.23
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
4
6
17
17
19
Basic Weighted Avg Shares
10
10
10
7
- -
Basic EPS, GAAP
2.3
-0.01
0.27
-1.36
- -
Basic EPS from Cont Ops
2.3
-0.01
0.27
-9.45
- -
Diluted Weighted Avg Shares
10
10
10
7
- -
Diluted EPS, GAAP
2.3
-0.01
0.27
-1.36
- -
Diluted EPS from Cont Ops
2.3
-0.01
0.27
-9.45
- -

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
- -
208
242
278
331
+ Cash, Cash Equivalents & STI
- -
27
37
64
73
+ Cash & Cash Equivalents
- -
27
27
29
63
+ ST Investments
- -
- -
10
35
10
+ Accounts & Notes Receiv
- -
138
166
165
190
+ Accounts Receivable, Net
- -
111
136
129
129
+ Notes Receivable, Net
- -
2
2
2
2
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
25
28
34
58
+ Inventories
- -
35
36
45
61
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
35
36
45
61
+ Other ST Assets
- -
8
3
4
8
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
40
84
97
139
+ Property, Plant & Equip, Net
- -
33
76
84
99
+ Property, Plant & Equip
- -
43
93
108
128
- Accumulated Depreciation
- -
11
17
25
30
+ LT Investments & Receivables
- -
- -
- -
2
- -
+ LT Investments
- -
- -
- -
2
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
7
9
11
40
+ Total Intangible Assets
- -
1
1
1
13
+ Goodwill
- -
- -
- -
1
11
+ Other Intangible Assets
- -
1
1
- -
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
6
7
10
27
Total Assets
- -
248
326
374
470
+ Payables & Accruals
- -
98
109
135
176
+ Accounts Payable
- -
93
106
128
171
+ Accrued Taxes
- -
- -
- -
4
1
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
5
2
3
4
+ ST Debt
- -
- -
10
8
12
+ ST Borrowings
- -
- -
- -
- -
4
+ ST Finance Leases
- -
- -
10
8
8
+ Other ST Liabilities
- -
21
22
26
29
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
21
22
26
29
Total Current Liabilities
- -
119
141
169
217
+ LT Debt
- -
64
118
120
135
+ LT Borrowings
- -
64
80
81
87
+ LT Finance Leases
- -
- -
37
40
48
+ Other LT Liabilities
- -
6
6
14
10
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
6
6
14
10
Total Noncurrent Liabilities
- -
69
123
135
145
Total Liabilities
- -
189
264
304
362
+ Preferred Equity and Hybrid Capital
- -
- -
- -
65
65
+ Share Capital & APIC
- -
36
36
- -
56
+ Common Stock
- -
36
36
- -
- -
+ Additional Paid in Capital
- -
- -
- -
- -
56
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
- -
23
26
-162
-102
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
60
62
-97
19
+ Minority/Non Controlling Interest
- -
- -
- -
167
89
Total Equity
- -
60
62
71
108
Total Liabilities & Equity
- -
248
326
374
470
Shares Outstanding
- -
10
10
10
27
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
47
48
56
Net Debt
- -
36
53
52
28
Net Debt to Equity
- -
61.03
86.07
73.68
25.94
Tangible Common Equity Ratio
- -
23.64
18.7
1.2
6.49
Current Ratio
- -
1.75
1.72
1.64
1.53
Cash Conversion Cycle
- -
9.95
17.1
14.73
5.66

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
22
- -
3
-63
-27
+ Depreciation & Amortization
4
6
17
17
19
+ Non-Cash Items
- -
2
1
16
23
+ Stock-Based Compensation
- -
- -
- -
5
16
+ Deferred Income Taxes
-1
1
- -
- -
3
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
1
2
1
11
4
+ Chg in Non-Cash Work Cap
12
-35
-27
12
-20
+ (Inc) Dec in Accts Receiv
-42
-39
-28
1
-22
+ (Inc) Dec in Inventories
-6
-10
-2
-8
-14
+ (Inc) Dec in Prepaid Assets
- -
-2
1
-2
-4
+ Inc (Dec) in Accts Payable
43
29
17
30
41
+ Inc (Dec) in Other
17
-13
-14
-9
-23
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
37
-26
-7
-18
-5
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
1
2
1
- -
+ Disp of Fixed Prod Assets
- -
1
2
1
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-12
-8
-7
-12
-21
+ Acq of Fixed Prod Assets
-12
-8
-7
-12
-21
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
28
- -
- -
55
50
+ Increase in Capital Stock
28
- -
- -
65
50
+ Decrease in Capital Stock
- -
- -
- -
-10
- -
+ Net Change in LT Investment
- -
- -
-10
-25
26
+ Dec in LT Investment
- -
- -
3
42
55
+ Inc in LT Investment
- -
- -
-13
-67
-29
+ Net Cash From Acq & Div
-1
-3
- -
- -
-7
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
-1
-3
- -
- -
-7
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
-2
- -
1
1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-15
-11
-14
-36
-2
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
-12
28
16
-1
-5
+ Cash From Debt
13
65
16
- -
- -
+ Repayments of Debt
-25
-37
- -
-1
-5
+ Other Financing Activities
- -
-1
- -
- -
-3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
16
27
15
55
42
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
39
-10
-5
2
34
EBITDA
26
7
26
-1
3
EBITDA Margin (%)
3.55
0.74
2.26
-0.09
0.19
Free Cash Flow
25
-35
-14
-30
-26
Net Cash Paid for Acquisitions
1
3
- -
- -
7
Free Cash Flow to Firm
- -
-35
-11
- -
- -
Free Cash Flow to Equity
- -
-6
4
31
-36
Free Cash Flow per Basic Share
2.63
-3.64
-1.47
-4.55
- -
Price/Free Cash Flow
- -
-5.16
234.23
-6.76
- -
Cash Flow to Net Income
1.7
250.84
-2.62
3.27
1.24
Capital Expenditures
-12
-8
-7
-12
-21